Cytotoxic Payloads For Antibody Drug Conjugates

Cytotoxic Payloads For Antibody Drug Conjugates Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Cytotoxic Payloads For Antibody Drug Conjugates book. This book definitely worth reading, it is an incredibly well-written.

Cytotoxic Payloads for AntibodyDrug Conjugates

David E Thurston,Paul J M Jackson
Cytotoxic Payloads for AntibodyDrug Conjugates Book PDF

Author : David E Thurston,Paul J M Jackson
Publisher : Royal Society of Chemistry
Page : 502 pages
File Size : 53,6 Mb
Release : 2019-07-11
Category : Medical
ISBN : 9781788018456

Get Book

Cytotoxic Payloads for AntibodyDrug Conjugates by David E Thurston,Paul J M Jackson Pdf

Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (KadcylaTM), brentuximab vedotin (AdcetrisTM), inotuzumab ozogamicin (BesponsaTM), gemtuzumab ozogamicin (MylotargTM) and moxetumomab pasudotox-tdfk (Lumoxiti®)] and over 70 others are in various stages of clinical development, with impressive interim results being reported for many. The technology is based on the concept of delivering a cytotoxic payload selectively to cancer cells by attaching it to an antibody targeted to antigens on the cell surfaces. This approach has several advantages including the ability to select patients as likely responders based on the presence of antigen on the surface of their cancer cells and a wider therapeutic index, given that ADC targeting enables a more efficient delivery of cytotoxic agents to cancer cells than can be achieved by conventional chemotherapy, thus minimising systemic toxicity. Although there are many examples of antibodies that have been developed for this purpose, along with numerous linker technologies used to attach the cytotoxic agent to the antibody, there is presently a relatively small number of payload molecules in clinical use. The purpose of this book is to describe the variety of payloads used to date, along with a discussion of their advantages and disadvantages and to provide information on novel payloads at the research stage that may be used clinically in the future.

Cytotoxic Payloads for Antibody–Drug Conjugates

David E Thurston,Paul J M Jackson
Cytotoxic Payloads for Antibody Drug Conjugates Book PDF

Author : David E Thurston,Paul J M Jackson
Publisher : Royal Society of Chemistry
Page : 502 pages
File Size : 44,9 Mb
Release : 2019-07-15
Category : Medical
ISBN : 9781788010771

Get Book

Cytotoxic Payloads for Antibody–Drug Conjugates by David E Thurston,Paul J M Jackson Pdf

Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadcyla™), brentuximab vedotin (Adcetris™), inotuzumab ozogamicin (Besponsa™), gemtuzumab ozogamicin (Mylotarg™) and moxetumomab pasudotox-tdfk (Lumoxiti®)] and over 70 others are in various stages of clinical development, with impressive interim results being reported for many. The technology is based on the concept of delivering a cytotoxic payload selectively to cancer cells by attaching it to an antibody targeted to antigens on the cell surfaces. This approach has several advantages including the ability to select patients as likely responders based on the presence of antigen on the surface of their cancer cells and a wider therapeutic index, given that ADC targeting enables a more efficient delivery of cytotoxic agents to cancer cells than can be achieved by conventional chemotherapy, thus minimising systemic toxicity. Although there are many examples of antibodies that have been developed for this purpose, along with numerous linker technologies used to attach the cytotoxic agent to the antibody, there is presently a relatively small number of payload molecules in clinical use. The purpose of this book is to describe the variety of payloads used to date, along with a discussion of their advantages and disadvantages and to provide information on novel payloads at the research stage that may be used clinically in the future.

Antibody-Drug Conjugates

Kenneth J. Olivier, Jr.,Sara A. Hurvitz
Antibody Drug Conjugates Book PDF

Author : Kenneth J. Olivier, Jr.,Sara A. Hurvitz
Publisher : John Wiley & Sons
Page : 560 pages
File Size : 52,8 Mb
Release : 2016-11-14
Category : Medical
ISBN : 9781119060802

Get Book

Antibody-Drug Conjugates by Kenneth J. Olivier, Jr.,Sara A. Hurvitz Pdf

Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells. • Discusses the basics, drug delivery strategies, pharmacology and toxicology, and regulatory approval strategies • Covers the conduct and design of oncology clinical trials and the use of ADCs for tumor imaging • Includes case studies of ADCs in oncology drug development • Features contributions from highly-regarded experts on the frontlines of ADC research and development

Chemical Linkers in Antibody-Drug Conjugates (ADCs)

Floris van Delft,John M. Lambert
Chemical Linkers in Antibody Drug Conjugates ADCs Book PDF

Author : Floris van Delft,John M. Lambert
Publisher : Royal Society of Chemistry
Page : 477 pages
File Size : 45,6 Mb
Release : 2021-12-22
Category : Medical
ISBN : 9781839162633

Get Book

Chemical Linkers in Antibody-Drug Conjugates (ADCs) by Floris van Delft,John M. Lambert Pdf

Chemical Linkers in Antibody-Drug Conjugates aims to shine a detailed light on the various key attributes of chemical linkers in ADCs, for drug-to-antibody ratio, for stability, for release mechanism of payload, for pharmacokinetics, for stability determination, and for efficacy and safety.

Antibody-Drug Conjugates

Laurent Ducry
Antibody Drug Conjugates Book PDF

Author : Laurent Ducry
Publisher : Humana
Page : 0 pages
File Size : 47,8 Mb
Release : 2016-08-23
Category : Medical
ISBN : 1493960261

Get Book

Antibody-Drug Conjugates by Laurent Ducry Pdf

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. In Antibody-Drug Conjugates, expert researchers provide detailed protocols for many of the key ADC techniques necessary for working in the field. These chapters and methodologies are aimed at the key tasks necessary to identify a suitable target, properly design the mAb, the linker and the payload, as well as to conjugate them in a reproducible and scalable fashion. Written in the highly successful Methods in Molecular BiologyTM format, these detailed chapters include the kind of practical implementation advice that guarantees quality results. Authoritative and timely, Antibody-Drug Conjugates aims to further drive ADC development and thus help toward improving cancer treatments of the future.

Antibody-Drug Conjugates and Immunotoxins

Gail Lewis Phillips
Antibody Drug Conjugates and Immunotoxins Book PDF

Author : Gail Lewis Phillips
Publisher : Springer Science & Business Media
Page : 370 pages
File Size : 55,7 Mb
Release : 2012-12-13
Category : Medical
ISBN : 9781461454564

Get Book

Antibody-Drug Conjugates and Immunotoxins by Gail Lewis Phillips Pdf

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Antibody-Drug Conjugates

Laurent Ducry
Antibody Drug Conjugates Book PDF

Author : Laurent Ducry
Publisher : Humana Press
Page : 317 pages
File Size : 55,6 Mb
Release : 2013-08-03
Category : Medical
ISBN : 1627035427

Get Book

Antibody-Drug Conjugates by Laurent Ducry Pdf

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. In Antibody-Drug Conjugates, expert researchers provide detailed protocols for many of the key ADC techniques necessary for working in the field. These chapters and methodologies are aimed at the key tasks necessary to identify a suitable target, properly design the mAb, the linker and the payload, as well as to conjugate them in a reproducible and scalable fashion. Written in the highly successful Methods in Molecular BiologyTM format, these detailed chapters include the kind of practical implementation advice that guarantees quality results. Authoritative and timely, Antibody-Drug Conjugates aims to further drive ADC development and thus help toward improving cancer treatments of the future.

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Ulf Grawunder,Stefan Barth
Next Generation Antibody Drug Conjugates ADCs and Immunotoxins Book PDF

Author : Ulf Grawunder,Stefan Barth
Publisher : Springer
Page : 181 pages
File Size : 46,8 Mb
Release : 2017-04-07
Category : Medical
ISBN : 9783319468778

Get Book

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins by Ulf Grawunder,Stefan Barth Pdf

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities. The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

Antibody-Drug Conjugates

Kenneth J. Olivier, Jr.,Sara A. Hurvitz
Antibody Drug Conjugates Book PDF

Author : Kenneth J. Olivier, Jr.,Sara A. Hurvitz
Publisher : John Wiley & Sons
Page : 572 pages
File Size : 52,6 Mb
Release : 2016-11-14
Category : Medical
ISBN : 9781119060680

Get Book

Antibody-Drug Conjugates by Kenneth J. Olivier, Jr.,Sara A. Hurvitz Pdf

Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells. • Discusses the basics, drug delivery strategies, pharmacology and toxicology, and regulatory approval strategies • Covers the conduct and design of oncology clinical trials and the use of ADCs for tumor imaging • Includes case studies of ADCs in oncology drug development • Features contributions from highly-regarded experts on the frontlines of ADC research and development

Sample Preparation in LC-MS Bioanalysis

Wenkui Li,Wenying Jian,Yunlin Fu
Sample Preparation in LC MS Bioanalysis Book PDF

Author : Wenkui Li,Wenying Jian,Yunlin Fu
Publisher : John Wiley & Sons
Page : 384 pages
File Size : 49,6 Mb
Release : 2019-03-12
Category : Science
ISBN : 9781119274292

Get Book

Sample Preparation in LC-MS Bioanalysis by Wenkui Li,Wenying Jian,Yunlin Fu Pdf

Revised and Expanded Handbook Provides Comprehensive Introduction and Complete Instruction for Sample Preparation in Vital Category of Bioanalysis Following in the footsteps of the previously published Handbook of LC-MS Bioanalysis, this book is a thorough and timely guide to all important sample preparation techniques used for quantitative Liquid Chromatography–Mass Spectrometry (LC-MS) bioanalysis of small and large molecules. LC-MS bioanalysis is a key element of pharmaceutical research and development, post-approval therapeutic drug monitoring, and many other studies used in human healthcare. While advances are continually being made in key aspects of LC-MS bioanalysis such as sensitivity and throughput, the value of research/study mentioned above is still heavily dependent on the availability of high-quality data, for which sample preparation plays the critical role. Thus, this text provides researchers in industry, academia, and regulatory agencies with detailed sample preparation techniques and step-by-step protocols on proper extraction of various analyte(s) of interest from biological samples for LC-MS quantification, in accordance with current health authority regulations and industry best practices. The three sections of the book with a total of 26 chapters cover topics that include: Current basic sample preparation techniques (e.g., protein precipitation, liquid-liquid extraction, solid-phase extraction, salting-out assisted liquid-liquid extraction, ultracentrifugation and ultrafiltration, microsampling, sample extraction via electromembranes) Sample preparation techniques for uncommon biological matrices (e.g., tissues, hair, skin, nails, bones, mononuclear cells, cerebrospinal fluid, aqueous humor) Crucial aspects of LC-MS bioanalytical method development (e.g., pre-analytical considerations, derivation strategies, stability, non-specific binding) in addition to sample preparation techniques for challenging molecules (e.g., lipids, peptides, proteins, oligonucleotides, antibody-drug conjugates) Sample Preparation in LC-MS Bioanalysis will prove a practical and highly valuable addition to the reference shelves of scientists and related professionals in a variety of fields, including pharmaceutical and biomedical research, mass spectrometry, and analytical chemistry, as well as practitioners in clinical pharmacology, toxicology, and therapeutic drug monitoring.

Innovations for Next-Generation Antibody-Drug Conjugates

Marc Damelin
Innovations for Next Generation Antibody Drug Conjugates Book PDF

Author : Marc Damelin
Publisher : Springer
Page : 357 pages
File Size : 48,9 Mb
Release : 2018-05-29
Category : Medical
ISBN : 9783319781549

Get Book

Innovations for Next-Generation Antibody-Drug Conjugates by Marc Damelin Pdf

Antibody-drug conjugates (ADCs) stand at the verge of a transformation. Scores of clinical programs have yielded only a few regulatory approvals, but a wave of technological innovation now empowers us to overcome past technical challenges. This volume focuses on the next generation of ADCs and the innovations that will enable them. The book inspires the future by integrating the field’s history with novel strategies and cutting-edge technologies. While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties. However, the combination of small and large molecules imposes deep complexity to lead optimization, pharmacokinetics, toxicology, analytics and manufacturing. The field has made significant advances in all of these areas by improving target selection, ADC design, manufacturing methods and clinical strategies. These innovations will inspire and educate scientists who are designing next-generation ADCs with the potential to transform the lives of patients.

Successful Drug Discovery, Volume 4

J¿nos Fischer,Christian Klein,Wayne E. Childers
Successful Drug Discovery Volume 4 Book PDF

Author : J¿nos Fischer,Christian Klein,Wayne E. Childers
Publisher : John Wiley & Sons
Page : 270 pages
File Size : 49,7 Mb
Release : 2019-11-11
Category : Medical
ISBN : 9783527344680

Get Book

Successful Drug Discovery, Volume 4 by J¿nos Fischer,Christian Klein,Wayne E. Childers Pdf

Provides unique insider insight into the current drug development process, and what it takes to achieve success In this fourth volume in the series, inventors and primary developers of drugs that made it to the market continue telling the story of the drugs? discovery and development, and discuss the sometimes twisted route from the first drug candidate molecule to the final marketed one. Beginning with a general section addressing overarching topics for drug discovery, the book offers seven chapters that feature selected case studies describing recently introduced drugs or drug classes. These include small molecule drugs as well as biopharmaceuticals and range across different therapeutic fields. Together, they provide a representative cross-section of the present-day drug development effort. Successful Drug Discovery: Volume 4 covers trends in peptide-based drug discovery and the physicochemical properties of recently approved oral drugs. The section on drug class studies looks at antibody-drug conjugates and the discovery, evolution, and therapeutic potential of dopamine partial agonists. Featured case studies examine the discovery of Etelcalcetide for the treatment of secondary hyper-parathyroidism in patients with chronic kidney disease; the development of Lenvatinib Mesylate; the discovery and development of Venetoclax; and more. -Focuses on recently introduced drugs that have not been featured in any textbooks or general references, including Ocrelizumab, a new generation of anti-CD-20 mAb for the treatment of multiple sclerosis, and Venetoclax, a selective antagonist of BCL-2 -Features personal experiences of successful drug developers from industry and academia -Endorsed and supported by the International Union of Pure and Applied Chemistry (IUPAC) Successful Drug Discovery: Volume 4 provides a fascinating and informative look into the process of drug discovery and would be a great reference for those in the pharmaceutical industry, organic and pharmaceutical chemists, and lecturers in pharmacy.

Antibody-Drug Conjugates and Immunotoxins

Gail Lewis Phillips
Antibody Drug Conjugates and Immunotoxins Book PDF

Author : Gail Lewis Phillips
Publisher : Springer
Page : 378 pages
File Size : 43,7 Mb
Release : 2012-12-12
Category : Medical
ISBN : 1461454573

Get Book

Antibody-Drug Conjugates and Immunotoxins by Gail Lewis Phillips Pdf

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Antibody-Drug Conjugates

Jeffrey Wang,Wei-Chiang Shen,Jennica L. Zaro
Antibody Drug Conjugates Book PDF

Author : Jeffrey Wang,Wei-Chiang Shen,Jennica L. Zaro
Publisher : Springer
Page : 252 pages
File Size : 43,7 Mb
Release : 2015-03-05
Category : Medical
ISBN : 9783319130811

Get Book

Antibody-Drug Conjugates by Jeffrey Wang,Wei-Chiang Shen,Jennica L. Zaro Pdf

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.

Biologics, Biosimilars, and Biobetters

Iqbal Ramzan
Biologics Biosimilars and Biobetters Book PDF

Author : Iqbal Ramzan
Publisher : John Wiley & Sons
Page : 328 pages
File Size : 53,5 Mb
Release : 2021-02-03
Category : Medical
ISBN : 9781119564652

Get Book

Biologics, Biosimilars, and Biobetters by Iqbal Ramzan Pdf

A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists